Skin Exposure Reduction Paste Against Chemical Warfare Agents is a drug owned by Us Army Medical Research And Material Command. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be May 30, 2015. Details of Skin Exposure Reduction Paste Against Chemical Warfare Agents's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5607979 | Topical skin protectants |
May, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Skin Exposure Reduction Paste Against Chemical Warfare Agents is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Skin Exposure Reduction Paste Against Chemical Warfare Agents's family patents as well as insights into ongoing legal events on those patents.
Skin Exposure Reduction Paste Against Chemical Warfare Agents's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Skin Exposure Reduction Paste Against Chemical Warfare Agents's generic launch date based on the expiry of its last outstanding patent is estimated to be May 30, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Skin Exposure Reduction Paste Against Chemical Warfare Agents Generics:
There are no approved generic versions for Skin Exposure Reduction Paste Against Chemical Warfare Agents as of now.
About Skin Exposure Reduction Paste Against Chemical Warfare Agents
Skin Exposure Reduction Paste Against Chemical Warfare Agents is a drug owned by Us Army Medical Research And Material Command. Skin Exposure Reduction Paste Against Chemical Warfare Agents uses Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene as an active ingredient. Skin Exposure Reduction Paste Against Chemical Warfare Agents was launched by Us Army Med Res in 2000.
Approval Date:
Skin Exposure Reduction Paste Against Chemical Warfare Agents was approved by FDA for market use on 17 February, 2000.
Active Ingredient:
Skin Exposure Reduction Paste Against Chemical Warfare Agents uses Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene as the active ingredient. Check out other Drugs and Companies using Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene ingredient
Dosage:
Skin Exposure Reduction Paste Against Chemical Warfare Agents is available in paste form for topical use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 50%;50% | PASTE | Discontinued | TOPICAL |